gnp hemorrhoidal maximum strength

Generic: hemorrhoidal

Labeler: amerisourcebergen drug corporation
NDC Directory HUMAN OTC DRUG OTC MONOGRAPH DRUG Inactive Finished

Drug Facts

Product Profile

Brand Name gnp hemorrhoidal maximum strength
Generic Name hemorrhoidal
Labeler amerisourcebergen drug corporation
Dosage Form CREAM
Routes
TOPICAL
Active Ingredients

glycerin 144 mg/g, petrolatum 150 mg/g, phenylephrine hydrochloride 25 mg/g, pramoxine hydrochloride 10 mg/g

Manufacturer
Amerisourcebergen Drug Corporation

Identifiers & Regulatory

Product NDC 46122-776
Product ID 46122-776_48647ad1-6530-61f9-e063-6294a90a3551
Product Type HUMAN OTC DRUG
Marketing Category OTC MONOGRAPH DRUG
Application Number M015
Listing Expiration 2027-12-31
Marketing Start 2024-10-09

Pharmacologic Class

Established (EPC)
non-standardized chemical allergen [epc]
Chemical Structure
allergens [cs] glycerol [cs]
Physiologic Effect
increased histamine release [pe] cell-mediated immunity [pe] increased igg production [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 46122776
Hyphenated Format 46122-776

Supplemental Identifiers

UPC
0346122776370
UNII
PDC6A3C0OX 4T6H12BN9U 04JA59TNSJ 88AYB867L5
NUI
N0000185370 N0000175629 N0000184306 N0000185001 M0000728 M0009417

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name gnp hemorrhoidal maximum strength (source: ndc)
Generic Name hemorrhoidal (source: ndc)
Application Number M015 (source: ndc)
Routes
TOPICAL
source: ndc

Resolved Composition

Strengths
  • 144 mg/g
  • 150 mg/g
  • 25 mg/g
  • 10 mg/g
source: ndc
Packaging
  • 1 TUBE in 1 CARTON (46122-776-37) / 25.5 g in 1 TUBE
source: ndc

Packages (1)

Ingredients (4)

glycerin (144 mg/g) petrolatum (150 mg/g) phenylephrine hydrochloride (25 mg/g) pramoxine hydrochloride (10 mg/g)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["TOPICAL"], "spl_id": "48647ad1-6530-61f9-e063-6294a90a3551", "openfda": {"nui": ["N0000185370", "N0000175629", "N0000184306", "N0000185001", "M0000728", "M0009417"], "upc": ["0346122776370"], "unii": ["PDC6A3C0OX", "4T6H12BN9U", "04JA59TNSJ", "88AYB867L5"], "spl_set_id": ["24103355-cd72-55b0-e063-6394a90a90ec"], "pharm_class_cs": ["Allergens [CS]", "Glycerol [CS]"], "pharm_class_pe": ["Increased Histamine Release [PE]", "Cell-mediated Immunity [PE]", "Increased IgG Production [PE]"], "pharm_class_epc": ["Non-Standardized Chemical Allergen [EPC]"], "manufacturer_name": ["Amerisourcebergen Drug Corporation"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 TUBE in 1 CARTON (46122-776-37)  / 25.5 g in 1 TUBE", "package_ndc": "46122-776-37", "marketing_start_date": "20241009"}], "brand_name": "GNP Hemorrhoidal Maximum Strength", "product_id": "46122-776_48647ad1-6530-61f9-e063-6294a90a3551", "dosage_form": "CREAM", "pharm_class": ["Adrenergic alpha1-Agonists [MoA]", "Allergens [CS]", "Cell-mediated Immunity [PE]", "Glycerol [CS]", "Increased Histamine Release [PE]", "Increased IgG Production [PE]", "Non-Standardized Chemical Allergen [EPC]", "alpha-1 Adrenergic Agonist [EPC]"], "product_ndc": "46122-776", "generic_name": "Hemorrhoidal", "labeler_name": "Amerisourcebergen Drug Corporation", "product_type": "HUMAN OTC DRUG", "brand_name_base": "GNP Hemorrhoidal", "brand_name_suffix": "Maximum Strength", "active_ingredients": [{"name": "GLYCERIN", "strength": "144 mg/g"}, {"name": "PETROLATUM", "strength": "150 mg/g"}, {"name": "PHENYLEPHRINE HYDROCHLORIDE", "strength": "25 mg/g"}, {"name": "PRAMOXINE HYDROCHLORIDE", "strength": "10 mg/g"}], "application_number": "M015", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20241009", "listing_expiration_date": "20271231"}